Evidence map›Paper›PMID 30279204›Full record

ArticleBioscience reports2018

Dihydro-sphingosine 1-phosphate interacts with carrier proteins in a manner distinct from that of sphingosine 1-phosphate.

Yuko Mishima, Makoto Kurano, Tamaki Kobayashi, Masako Nishikawa, Ryunosuke Ohkawa, Minoru Tozuka, Yutaka Yatomi

Open access · goldAbstract read
In one paragraph

Article in Bioscience reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Yuko MishimaDepartment of Clinical Laboratory Medicine, The University of Tokyo, Tokyo, Japan.
Makoto KuranoDepartment of Clinical Laboratory Medicine, The University of Tokyo, Tokyo, Japan kurano-tky@umin.ac.jp yatoyuta-tky@umin.ac.jp.ORCID 0000-0002-2596-1145
Tamaki KobayashiDepartment of Clinical Laboratory Medicine, The University of Tokyo, Tokyo, Japan.
Masako NishikawaDepartment of Clinical Laboratory Medicine, The University of Tokyo, Tokyo, Japan.
Ryunosuke OhkawaAnalytical Laboratory Chemistry, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
Minoru TozukaAnalytical Laboratory Chemistry, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
Yutaka YatomiDepartment of Clinical Laboratory Medicine, The University of Tokyo, Tokyo, Japan.
Tokyo Medical and Dental University · JPThe University of Tokyo · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dihydro-sphingosine 1-phosphate (DH-S1P) is an analog of sphingosine 1-phosphate (S1P), which is a potent lysophospholipid mediator. DH-S1P has been proposed to exert physiological properties similar to S1P. Although S1P is known to be carried on HDL via apolipoprotein M (apoM), the association between DH-S1P and HDL/apoM has not been fully elucidated. Therefore, in the present study, we aimed to elucidate this association and to compare it with that of S1P and HDL/apoM. First, we investigated the distributions of S1P and DH-S1P among lipoproteins and lipoprotein-depleted fractions in human serum and plasma samples and observed that both S1P and DH-S1P were detected on HDL; furthermore, elevated amounts of DH-S1P in serum samples were distributed to the lipoprotein-depleted fraction to a greater degree than to the HDL fraction. Concordantly, a preference for HDL over albumin was only observed for S1P, and not for DH-S1P, when the molecules were secreted from platelets. Regarding the association with HDL, although both S1P and DH-S1P prefer to bind to HDL, HDL preferentially accepts S1P over DH-S1P. For the association with apoM, S1P was not detected on HDL obtained from apoM knockout mice, while DH-S1P was detected. Moreover, apoM retarded the degradation of S1P, but not of DH-S1P. These results suggest that S1P binds to HDL via apoM, while DH-S1P binds to HDL in a non-specific manner. Thus, DH-S1P is not a mere analog of S1P and might possess unique clinical significance.

Indexed as

AnimalsApolipoproteins MBlood PlateletsCarrier ProteinsCells, CulturedErythrocytesHep G2 CellsHumansKineticsLipoproteins, HDLLysophospholipidsMaleMiceMice, Inbred C57BLMice, KnockoutProtein BindingApolipoproteins MCarrier Proteinsdihydrosphingosine 1-phosphateLipoproteins, HDLLysophospholipidsSerum AlbuminSphingosinesphingosine 1-phosphateapolipoprotein Mdihydro-sphingosine 1-phosphateHDLsphingosine 1-phosphate

Identifiers

PMID30279204
PMCPMC6209608
OpenAlexW2895024648

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.